Interactive Biosoftware introduces Alamut HT
A comprehensive and powerful new annotation solution for NGS
SAN DIEGO, CA Mar. 28, 2012 – Interactive Biosoftware, developer of Alamut, the world’s original mutation interpretation software, unveils Alamut HT at the Annual Clinical Genetics Meeting in Charlotte, NC from March 28th to March 30th.
Alamut HT is a comprehensive human genomic variation annotation and interpretation solution. As a high-throughput annotation engine for next-generation sequencing (NGS), it is designed for intensive variant analysis workflows. This new software enriches raw NGS variants with dozens of attributes, including effects on human genes, detailed single nucleotide polymorphisms (SNP) information, and missense and splicing predictions.
“Alamut HT’s splicing predictions are a unique feature not included by any other software on the market,” said André Blavier, Founder and CEO of Interactive Biosoftware. “Another distinctive aspect of the software is that it can be deployed either as a cloud-based client-server system, or as a full standalone installation that includes an automatically updatable database.”
Alamut HT is complementary software to Alamut, a rich graphical application for variant interpretation which greatly improved the working process for researchers and geneticists. Prior to the introduction of Alamut, researchers had to manually gather information from dozens of databases and websites—an extremely tedious and time consuming process. The new Alamut HT software brings even greater efficiency to the researcher and is comprehensive, adaptable, and scalable.
“Next-generation sequencing is a revolution that raises a number of scalability issues. Alamut HT intends to be part of the solution,” said Blavier.
Interactive Biosoftware products are the software of choice for leading university medical centers, hospitals, and private human genome laboratories worldwide. Interactive Biosoftware has established significant relations in Western Europe, and in the United States, with Harvard University, Columbia University and the Mayo Clinic. The products are currently used by over 200 entities in 26 countries on five continents around the world.
About Interactive Biosoftware: Established in April 2007 and headquartered in Rouen, France, Interactive Biosoftware (IB) was founded by a group of medical and computer scientists focusing on practical software applications for health care and life sciences, particularly in the field of molecular biology. The company engineers and manufactures the world-renowned decision software, Alamut, which aids geneticists and researchers in interpreting mutations and variations in human genes. The software makes appropriate diagnostics, surveillance, and information-sharing between, and across, all tiers of human genome research. IB strives to play an active role in the process of understanding and finding solutions for society’s most devastating diseases. For more information, please visit www.interactive-biosoftware.com, contact us at email@example.com, or call us at (619)-312-4444.
o: (858) 946-0246
c: (973) 449-0921